Matrix Private Capital Group LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 400 shares of the financial services provider’s stock, valued at approximately $52,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Flow Traders U.S. LLC acquired a new position in iShares Biotechnology ETF during the first quarter worth about $3,117,000. Hanseatic Management Services Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $1,581,000. Lauer Wealth LLC acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $1,528,000. Mogy Joel R Investment Counsel Inc. acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $126,000. Finally, Renaissance Technologies LLC acquired a new position in shares of iShares Biotechnology ETF during the first quarter worth $1,615,000. Institutional investors and hedge funds own 69.61% of the company’s stock.
iShares Biotechnology ETF Price Performance
NASDAQ IBB opened at $126.85 on Monday. The company’s fifty day simple moving average is $127.96 and its 200-day simple moving average is $129.44. iShares Biotechnology ETF has a 52 week low of $113.37 and a 52 week high of $138.74.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading
- Five stocks we like better than iShares Biotechnology ETF
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 9/4 – 9/8
- Overbought Stocks Explained: Should You Trade Them?
- The Best 5 Small Cap AI Companies to Buy Now
- How to Calculate Stock Profit
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
